Graft-versus-myeloma effect: Proof of principle

Blood

Volumn 87, Issue 3, 1996, Pages 1196-1198

  Tricot, Guido ^a,b   Vesole, David H ^a   Jagannath, Sundar ^a   Hilton, Jennifer ^a   Munshi, Nikhil ^a   Barlogie, Bart ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Division of Hematology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

M PROTEIN;

ADULT; ALLOGRAFT; ARTICLE; CANCER REGRESSION; CASE REPORT; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0030043438     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.3.1196.bloodjournal8731196     Document Type: Article

References (26)

1. Billingham RE: The biology of graft-versus-host reactions. Harvey Lect 62:21, 1967
2. Antin JH, Ferrara JLM: Cytokine dysregulation and acute graft-versus-host disease. Blood 80:2964, 1992
3. Barnes DWH, Loutit JF, Neal FE: Treatment of murine leukaemia with x-rays and homologous bone marrow. Br Med J 2:626, 1956
4. Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED: Antileukemic effect of chronic graft-versus-host disease. N Engl J Med 304.1529, 1981
5. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb H-J, Rimm AA, Ringden O, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM: Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75:555, 1990
6. Gale RP, Horowitz MM, Ash RC, Champlin RE, Goldman JM, Rimm AA, Ringden O, Stone JAV, Bortin MM: Identical-twin bone marrow transplants for leukemia. Ann Intern Med 120:646, 1994
7. Odom LF, Githens JH, Morse H, Sharma B, August CS, Humbert JR, Peakman D, Rusnak SL, Johnson FB: Remission of relapsed leukaemia during a graft-versus-host reaction. Lancet 2:537, 1978
8. Collins RH, Rogers ZR, Bennett M, Kumar V, Nikein A, Fay JW: Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation: Apparent graft-versus-leukemia effect following abrupt discontinuation of immunosuppression. Bone Marrow Transplant 10:391, 1992
9. Jones RJ, Ambinder RF, Piantadosi S, Santos GW: Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood 77:649, 1991
10. Kolb HJ, Mittermuller J, Clemm Ch, Holler E, Ledderose G, Brehm G, Heim M, Wilmanns W: Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76:2462, 1990
11. Bär BMAM, Schattenberg A, Mensink EJBM, Van Kessel AG, Smetsers TFCM, Knops GHJN, Linders EHP, De Witte T: Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation. J Clin Oncol 11:513, 1993
12. Drobyski WR, Keever CA, Roth MS, Koethe S, Hanson G, McFadden P, Gottschall JL, Ash RC, van Tuinen P, Horowitz MM, Flomenberg N: Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: Efficacy and toxicity of a defined T-cell dose. Blood 82:2310, 1993
13. Porter DL, Roth MS, McGarigle C, Ferrara JLM, Antin JH: Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N Engl J Med 330:100, 1994
14. Antin JH: Graft-versus-leukemia: No longer an epiphenomenon. Blood 82:2273, 1993
15. Johnson BD, Truitt RL: A decrease in graft-vs.-host disease without loss of graft-vs.-leukemia reactivity after MHC-matched bone marrow transplantation by selective depletion of donor NK cells in vivo. Transplant 54:104, 1990
16. Okunewick JP, Kociban DL, Machen LL, Buffo MJ: The role of CD4 and CD8 T cells in the graft-versus-leukemia response in Rauscher murine leukemia. Bone Marrow Transplant 8:445, 1991
17. Barlogie B, Smith L, Alexanian R: Effective treatment of advanced multiple myeloma refractory to alkylating agents. N Engl J Med 310:1353, 1984
18. Barlogie B, Alexanian R, Perhouse M, Smallwood L, Smith L: Cytoplasmic immunoglobulin content in multiple myeloma. J Clin Invest 76:765, 1985
19. Mackinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH, Boulad F, Castro-Malaspina H, Childs B, Gillio A, Kernan NA, Small T, Young J, O'Reilly RJ: Adoptive immunotherapy using escalating doses of donor leukocytes for relapsed chronic myeloid leukemia following allogeneic bone marrow transplantation. Blood 84:538a, 1994 (suppl 1, abstr)
20. Van Rhee F, Lin F, Cullis JO, Spencer A, Cross NCP, Chase A, Garicochea B, Bungey J, Barrett J, Goldman JM: Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: The case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood 83:3377, 1994
21. Helg C, Roux E, Beris P, Cabrol C, Wacker P, Darbellay R, Wyss M, Jeannet M, Chapuis B, Roosnek E: Adoptive immunotherapy for recurrent CML after BMT. Bone Marrow Transplant 12:125, 1993
22. Immunoglobulins I: Structure and function, in Stites DP, Stobo JD, Fudenberg HH, Wells JV (eds): Basic and Clinical Immunology. Los Altos, CA, Lange Medical, 1982
23. Boranic M: Transplantability of leukaemia from leukaemic mice after irradiation and injection of allogeneic spleen cells. Eur J Clin Biol Res 15:104, 1970
24. Boranic M, Tonkovic I: Time pattern of the antileukemic effect of graft-versus-host reaction. Cancer Res 31:1140, 1971
25. Boranic M: Transient graft-versus-host reaction in the treatment of leukemia in mice. J Natl Cancer Inst 41:421, 1968
26. Tiberghien P, Reynolds CW, Keller J, Spence S, Deschaseaux M, Certoux J-M, Contassot E, Murphy WJ, Lyons R, Chiang Y, Herve P, Longo DL, Ruscetti FW: Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: An approach for specific in vivo donor T cell depletion after bone marrow transplantation? Blood 84:1333, 1994